|
1
|
National Comprehensive Cancer Network, .
Rectal Cancer, Version 3. 2015.http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdfJune
23–2015
|
|
2
|
Glimelius B, Tiret E, Cervantes A and
Arnold D: ESMO Guidelines Working Group: Rectal cancer: ESMO
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 24:(Sul 6). vi81–vi88. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marijnen CA and Glimelius B: The role of
radiotherapy in rectal cancer. Eur J Cancer. 38:943–952. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sauer R, Becker H, Hohenberger W, et al:
German Rectal Cancer Study Group: Preoperative versus postoperative
chemoradiotherapy for rectal cancer. N Engl J Med. 351:1731–1740.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wagman R, Minsky BD, Cohen AM, Guillem JG
and Paty PP: Sphincter preservation in rectal cancer with
preoperative radiation therapy and coloanal anastomosis: Long term
follow-up. Int J Radiat Oncol Biol Phys. 42:51–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frykholm GJ, Isacsson U, Nygård K, et al:
Preoperative radiotherapy in rectal carcinoma - aspects of acute
adverse effects and radiation technique. Int J Radiat Oncol Biol
Phys. 35:1039–1048. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ceelen W, Fierens K, Van Nieuwenhove Y and
Pattyn P: Preoperative chemoradiation versus radiation alone for
stage II and III resectable rectal cancer: A systematic review and
meta-analysis. Int J Cancer. 124:2966–2972. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wada H, Nemoto K, Nomiya T, et al: A phase
I trial of S-1 with concurrent radiotherapy in patients with
locally recurrent rectal cancer. Int J Clin Oncol. 18:273–278.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morimoto S, Shimada M, Kurita N, et al:
Preoperative radiotherapy combined with S-1 for advanced lower
rectal cancer: Phase I trial. Hepatogastroenterology. 59:1428–1432.
2012.PubMed/NCBI
|
|
10
|
Doi H, Beppu N, Odawara S, et al:
Neoadjuvant short-course hyperfractionated accelerated radiotherapy
(SC-HART) combined with S-1 for locally advanced rectal cancer. J
Radiat Res (Tokyo). 54:1118–1124. 2013. View Article : Google Scholar
|
|
11
|
Beppu N, Matsubara N, Noda M, et al: The
timing of surgery after preoperative short-course S-1
chemoradiotherapy with delayed surgery for T3 lower rectal cancer.
Int J Colorectal Dis. 29:1459–1466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beppu N, Matsubara N, Kakuno A, et al:
Feasibility of modified short-course radiotherapy combined with a
chemoradiosensitizer for T3 rectal cancer. Dis Colon Rectum.
58:479–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sato T, Ozawa H, Hatate K, et al: A Phase
II trial of neoadjuvant preoperative chemoradiotherapy with S-1
plus irinotecan and radiation in patients with locally advanced
rectal cancer: Clinical feasibility and response rate. Int J Radiat
Oncol Biol Phys. 79:677–683. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chenevert TL, Stegman LD, Taylor JM, et
al: Diffusion magnetic resonance imaging: An early surrogate marker
of therapeutic efficacy in brain tumors. J Natl Cancer Inst.
92:2029–2036. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hamstra DA, Rehemtulla A and Ross BD:
Diffusion magnetic resonance imaging: A biomarker for treatment
response in oncology. J Clin Oncol. 25:4104–4109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DeSouza NM, Riches SF, Vanas NJ, et al:
Diffusion-weighted magnetic resonance imaging: A potential
non-invasive marker of tumour aggressiveness in localized prostate
cancer. Clin Radiol. 63:774–782. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SH, Lee JM, Hong SH, et al: Locally
advanced rectal cancer: Added value of diffusion-weighted MR
imaging in the evaluation of tumor response to neoadjuvant chemo-
and radiation therapy. Radiology. 253:116–125. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Monguzzi L, Ippolito D, Bernasconi DP, et
al: Locally advanced rectal cancer: Value of ADC mapping in
prediction of tumor response to radiochemotherapy. Eur J Radiol.
82:234–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lambregts DM, Maas M, Riedl RG, et al:
Value of ADC measurements for nodal staging after chemoradiation in
locally advanced rectal cancer - a per lesion validation study. Eur
Radiol. 21:265–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Curvo-Semedo L, Lambregts DM, Maas M, et
al: Rectal cancer: Assessment of complete response to preoperative
combined radiation therapy with chemotherapy - conventional MR
volumetry versus diffusion-weighted MR imaging. Radiology.
260:734–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ,
Cai SJ and Zhang Z: Diffusion-weighted magnetic resonance imaging
for predicting the response of rectal cancer to neoadjuvant
concurrent chemoradiation. World J Gastroenterol. 19:5520–5527.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dzik-Jurasz A, Domenig C, George M, et al:
Diffusion MRI for prediction of response of rectal cancer to
chemoradiation. Lancet. 360:307–308. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barbaro B, Vitale R, Valentini V, et al:
Diffusion-weighted magnetic resonance imaging in monitoring rectal
cancer response to neoadjuvant chemoradiotherapy. Int J Radiat
Oncol Biol Phys. 83:594–599. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ha HI, Kim AY, Yu CS, Park SH and Ha HK:
Locally advanced rectal cancer: Diffusion-weighted MR tumour
volumetry and the apparent diffusion coefficient for evaluating
complete remission after preoperative chemoradiation therapy. Eur
Radiol. 23:3345–3353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lambregts DM, Vandecaveye V, Barbaro B, et
al: Diffusion-weighted MRI for selection of complete responders
after chemoradiation for locally advanced rectal cancer: A
multicenter study. Ann Surg Oncol. 18:2224–2231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SH, Lee JY, Lee JM, Han JK and Choi
BI: Apparent diffusion coefficient for evaluating tumour response
to neoadjuvant chemoradiation therapy for locally advanced rectal
cancer. Eur Radiol. 21:987–995. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lambrecht M, Deroose C, Roels S, et al:
The use of FDG-PET/CT and diffusion-weighted magnetic resonance
imaging for response prediction before, during and after
preoperative chemoradiotherapy for rectal cancer. Acta Oncol.
49:956–963. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lambregts DM, Beets GL, Maas M, et al:
Tumour ADC measurements in rectal cancer: Effect of ROI methods on
ADC values and interobserver variability. Eur Radiol. 21:2567–2574.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim JC, Lim JS, Keum KC, et al: Comparison
of diffusion-weighted MRI and MR volumetry in the evaluation of
early treatment outcomes after preoperative chemoradiotherapy for
locally advanced rectal cancer. J Magn Reson Imaging. 34:570–576.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
DeVries AF, Kremser C, Hein PA, et al:
Tumor microcirculation and diffusion predict therapy outcome for
primary rectal carcinoma. Int J Radiat Oncol Biol Phys. 56:958–965.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eisenhauer EA, Therasse P, Bogaerts J, et
al: New response evaluation criteria in solid tumours: Revised
RECIST guideline (v1.1). Eur J Cancer. 45:228–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Toiyama Y, Inoue Y, Saigusa S, et al:
C-reactive protein as predictor of recurrence in patients with
rectal cancer undergoing chemoradiotherapy followed by surgery.
Anticancer Res. 33:5065–5074. 2013.PubMed/NCBI
|
|
33
|
Beppu N, Matsubara N, Noda M, et al:
Pathologic evaluation of the response of mesorectal positive nodes
to preoperative chemoradiotherapy in patients with rectal cancer.
Surgery. 157:743–751. 2015. View Article : Google Scholar : PubMed/NCBI
|
